The importance and meaning of this interaction need to be further analyzed in vivo, given the fact that PPARγ is considered a tumor suppressor gene and clinical trials using PPARγ-agonists in the treatment of cancer are in course [85]. The gene discussed is PPARG; the disease is cancer.